scholarly journals Recommendations for the diagnosis and treatment of Clostridioides difficile infection: An official clinical practice guideline of the Spanish Society of Chemotherapy (SEQ), Spaish Society of Internal Medicine (SEMI) and the working group of Postoperative Infection of the Spanish Society of Anesthesia and Reanimation (SEDAR)

2020 ◽  
Vol 33 (02) ◽  
pp. 151-175
Author(s):  
Emilio Bouza ◽  
◽  
José María Aguado ◽  
Luis Alcalá ◽  
Benito Almirante ◽  
...  
2021 ◽  
Vol 73 (5) ◽  
pp. 755-757 ◽  
Author(s):  
Stuart Johnson ◽  
Valéry Lavergne ◽  
Andrew M Skinner ◽  
Anne J Gonzales-Luna ◽  
Kevin W Garey ◽  
...  

Abstract This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI. This guideline was developed by a multidisciplinary panel representing the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). This guideline is intended for use by healthcare professionals who care for adults with CDI, including specialists in infectious diseases, gastroenterologists, hospitalists, pharmacists, and any clinicians and healthcare providers caring for these patients. The panel’s recommendations for the management CDI are based upon evidence derived from topic-specific systematic literature reviews. Summarized below are the recommendations for the management of CDI in adults. The panel followed a systematic process which included a standardized methodology for rating the certainty of the evidence and strength of recommendation using the GRADE approach (Grading of Recommendations Assessment, Development, and Evaluation). A detailed description of background, methods, evidence summary and rationale that support each recommendation, and knowledge gaps can be found online in the full text.


Author(s):  
Goce Spasovski ◽  
Raymond Vanholder ◽  
Bruno Allolio ◽  
Djillali Annane ◽  
Steve Ball ◽  
...  

2010 ◽  
Vol 49 (3) ◽  
pp. S1-S19 ◽  
Author(s):  
James L. Thomas ◽  
Jeffrey C. Christensen ◽  
Steven R. Kravitz ◽  
Robert W. Mendicino ◽  
John M. Schuberth ◽  
...  

2014 ◽  
Vol 171 (1) ◽  
pp. X1 ◽  
Author(s):  
Goce Spasovski ◽  
Raymond Vanholder ◽  
Bruno Allolio ◽  
Djillali Annane ◽  
Steve Ball ◽  
...  

2014 ◽  
Vol 12 (2) ◽  
pp. 65-74 ◽  
Author(s):  
Goce Spasovski ◽  
Raymond Vanholder ◽  
Bruno Allolio ◽  
Djillali Annane ◽  
Steve Ball ◽  
...  

Abstract Hyponatraemia, defined as a serum sodium concentration <135 mmol/l, is the most common disorder of body fuid and electrolyte balance encountered in clinical practice. It can lead to a wide spectrum of clinical symptoms, from subtle to severe or even life threatening, and is associated with increased mortality, morbidity and length of hospital stay in patients presenting with a range of conditions. Despite this, the management of patients remains problematic. The prevalence of hyponatraemia in widely different conditions and the fact that hyponatraemia is managed by clinicians with a broad variety of backgrounds have fostered diverse institution-and speciality-based approaches to diagnosis and treatment. To obtain a common and holistic view, the European Society of Intensive Care Medicine (ESICM), the European Society of Endocrinology (ESE) and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA), represented by European Renal Best Practice (ERBP), have developed the Clinical Practice Guideline on the diagnostic approach and treatment of hyponatraemia as a joint venture of three societies representing specialists with a natural interest in hyponatraemia. In addition to a rigorous approach to methodology and evaluation, we were keen to ensure that the document focused on patient-important outcomes and included utility for clinicians involved in everyday practice.


Sign in / Sign up

Export Citation Format

Share Document